Skip to main content
. 2018 Jan 9;17(3):4273–4280. doi: 10.3892/mmr.2018.8414

Figure 3.

Figure 3.

Protein expression of uPA and MMP-2 following treatment with amiloride. The protein expression levels of (A) uPA and (B) MMP-2 in HeLa cells treated with different concentrations of amiloride, and of (C) uPA and (D) MMP-2 across different time periods, were detected by quantitative ELISA. With increasing amiloride concentration and treatment duration, the protein expression of uPA and MMP-2 decreased. *P<0.05 vs. respective control. uPA, urokinase plasminogen activator; MMP-2, 72 kDa type IV collagenase.